APA (7th ed.) Citation

Babcock, M. C., Mikulka, C. R., Wang, B., Chandriani, S., Chandra, S., Xu, Y., . . . Crawford, B. E. (2021). Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Scientific Reports, 11(1), 1. https://doi.org/10.1038/s41598-021-93601-1

Chicago Style (17th ed.) Citation

Babcock, Michael C., et al. "Substrate Reduction Therapy for Krabbe Disease and Metachromatic Leukodystrophy Using a Novel Ceramide Galactosyltransferase Inhibitor." Scientific Reports 11, no. 1 (2021): 1. https://doi.org/10.1038/s41598-021-93601-1.

MLA (9th ed.) Citation

Babcock, Michael C., et al. "Substrate Reduction Therapy for Krabbe Disease and Metachromatic Leukodystrophy Using a Novel Ceramide Galactosyltransferase Inhibitor." Scientific Reports, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1038/s41598-021-93601-1.